Trademark Details For MYDEPJEO (Serial Number 79351827)

MYDEPJEO
  • Rank
    Global Trademark Influence Ranking
    9722
  • Brand Index
    Global Trademark Influence Ranking Index
    0.13
4
34
13
3
  • Active Office Actions0
  • Conflicts0
  • Infringement0
Basic Information
  View Details
Serial Number  United States - USPTO 79351827
Registration Number -
MarkMYDEPJEO
Filing Date Aug-25-2022
Status
Pending   PUBLISHED FO.. (686)
Attorney Name


  • 1   Novartis
    CH


005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active




Correspondences

NameMaury M. Tepper, III
AddressTepper & Eyster, PLLC 3724 BENSON DR RALEIGH NC 27609

Prosecution History

USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Feb-21-2023NOTIFICATION PROCESSED BY IB   GPNXP
Feb-21-2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Feb-21-2023PUBLISHED FOR OPPOSITION   PUBOA
Feb-01-2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB   OPNSP
Feb-01-2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB   OP2RP
Feb-01-2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Jan-17-2023APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Jan-17-2023NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW   RFWRP
Nov-07-2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED   CHANI
Nov-07-2022TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Nov-07-2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS   ECDRI
Nov-07-2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
Nov-07-2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
Nov-07-2022TEAS CHANGE OF OWNER ADDRESS RECEIVED   COARI
Nov-06-2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW   RFCRE
Nov-05-2022NON-FINAL ACTION WRITTEN   CNRTR
Nov-03-2022ASSIGNED TO EXAMINER   DOCKD
Oct-21-2022APPLICATION FILING RECEIPT MAILED   MAFRO
Oct-17-2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Oct-14-2022LIMITATION FROM ORIGINAL APPLICATION ENTERED   LIMII
Oct-06-2022SN ASSIGNED FOR SECT 66A APPL FROM IB   REPRM